Case Control Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Dec 15, 2019; 11(12): 1126-1140
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1126
Table 1 Patient characteristics in the adenocarcinoma and control groups, n (%)
CharacteristicsPDAC (n = 114)Control (n = 125)
Age (yr), mean (SD)64.76 (10.58)b60.26 (12.03)
Age > 50 yr103 (90.35)b89 (71.2)
Sex (female)47 (41.23)46 (36.8)
BMI (kg/m2), median (IQR)25.09 (22.05-27.25)25.26 (22.58-28.72)
Weight status
Underweight12 (10.53)5 (4)
Normal48 (42.11)53 (42.4)
Overweight37 (32.46)44 (35.2)
Obesity17 (14.91)23 (18.4)
Smoking50 (43.86)69 (55.2)
New-onset diabetes24 (21.05)b8 (6.4)
Long-term diabetes24 (21.05)32 (25.6)
Diabetes49 (42.98)a38 (30.4)
CA 19-9 (U/mL), median (IQR)400 (67.75-400)b31.45 (9.58-98.8)
Cachexia22 (19)8 (6)
T stage1-2: 10 (8.85); 3: 65 (57.52); 4: 38 (33.63)
Histological gradeG1: 8/41 (19.51); G2: 24/41 (58.54); G3: 12/41 (29.27)
N stage9 (8.18)
Metastasis48 (42.11)